Atovaquone/proguanil for plasmodium falciparum malaria

Pediatr Infect Dis J. 2002 Aug;21(8):787-9. doi: 10.1097/00006454-200208000-00017.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antimalarials / administration & dosage
  • Antimalarials / adverse effects
  • Antimalarials / therapeutic use
  • Atovaquone
  • Controlled Clinical Trials as Topic
  • Drug Combinations
  • Humans
  • Malaria, Falciparum / drug therapy*
  • Malaria, Falciparum / parasitology
  • Naphthoquinones / administration & dosage
  • Naphthoquinones / adverse effects
  • Naphthoquinones / therapeutic use*
  • Plasmodium falciparum / drug effects
  • Proguanil / administration & dosage
  • Proguanil / adverse effects
  • Proguanil / therapeutic use*

Substances

  • Antimalarials
  • Drug Combinations
  • Naphthoquinones
  • Proguanil
  • Atovaquone